Active not recruitingOBSERVATIONAL

CCP Cancer UK Companion Study

This UK study is all about understanding how COVID-19 affects people who also have cancer. Doctors don't know much yet about the risks involved for cancer patients. Researchers are looking at symptoms, treatments, and how people recover. They'll also explore if the type of cancer or its treatment makes a difference, and compare these experiences to people who have COVID-19 but don't have cancer. The goal is to gather vital information to help doctors make better decisions and create guidelines for caring for cancer patients during outbreaks of viruses like COVID-19 in the future.

At a glance

Status

Active not recruiting

Sponsor

The Clatterbridge Cancer Centre NHS Foundation Trust

Enrolment target

9,000

Start

28 Feb 2021

Estimated completion

31 Oct 2025

Cancer Covid19

What is this study about?

When the COVID-19 pandemic started, doctors and researchers quickly realised they didn't know much about how serious the virus would be for people who already had cancer. Cancer and some cancer treatments can weaken a person's immune system, making them more vulnerable to infections. This study, called the CCP Cancer UK Companion Study, was set up to gather important information about this.

The main aim of this study is to understand exactly what happens when someone with cancer gets COVID-19. This includes looking at their symptoms, how they are treated, and how they recover. The study also wants to see if different types of cancer or different cancer treatments affect how serious COVID-19 becomes. By comparing these experiences with people who have COVID-19 but don't have cancer, doctors can learn a lot about the specific risks for cancer patients.

The information gathered from this study is really important. It will help doctors in the future to better understand and care for cancer patients if there are new outbreaks of viruses like COVID-19. It could also lead to new guidelines on how best to treat and support cancer patients during such challenging times, ultimately improving their care and safety.

Key takeaways

This study helps understand COVID-19 in cancer patients.
It collects information on symptoms, treatment, and recovery.
It aims to improve future care guidelines for cancer patients.
It involves reviewing your existing medical records.
Participation is entirely voluntary.
Your information will be kept confidential.

Who may be eligible?

To be part of this study, you must have a confirmed COVID-19 infection and also have a diagnosis of cancer. You would also need to be already taking part in another main study about COVID-19 in the UK called the 'Principal CCP-UK protocol'.

There are no additional reasons that would stop you from joining this study, other than those already mentioned in the main 'Principal CCP-UK protocol' you are part of.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Do you have a diagnosis of cancer?
Have you had a confirmed COVID-19 infection?
Are you currently taking part in the 'Principal CCP-UK protocol' study?
Are you happy for your medical records to be used for research?

Answer every question to see your result.

What does participation involve?

This study primarily involves collecting and looking at information from medical records of people who already have cancer and have also tested positive for COVID-19. You wouldn't be asked to take any new medication or have extra clinic visits specifically for this study. The researchers will gather details about your symptoms, treatments you received, and how you recovered from COVID-19, as well as information about your cancer type and treatment.

Since this study collects information from existing medical records, there aren't any specific extra steps or actions you would need to take. Your participation would mainly mean that your medical information, with your permission, is used to help researchers learn more. The duration of your involvement would depend on how long your medical information is followed within the main 'Principal CCP-UK protocol' you are already part of.

Potential risks and benefits

The main benefit of taking part is helping researchers understand more about how COVID-19 affects people with cancer, which could lead to better care for others in the future. As this study mainly uses existing medical information, there are very few direct risks. Your personal information will be kept confidential. You have the right to withdraw from the study at any time, which means your information would no longer be used.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.

The Clatterbridge Cancer Centre NHS Foundation Trust
Verified postcode
Liverpool, United Kingdom

Common questions

What is the main goal of this study?

The main goal is to understand how COVID-19 affects people with cancer, including their symptoms, treatment, and recovery, to improve future care.

Who can take part in this study?

You can take part if you have a confirmed COVID-19 infection, have a cancer diagnosis, and are already enrolled in the 'Principal CCP-UK protocol' study.

Will I need to take new medicines or have extra doctor visits?

No, this study mainly collects information from your existing medical records. You won't need new medicines or extra visits specifically for this study.

Is my personal information kept private?

Yes, all your personal and medical information will be kept confidential and handled securely by the study team.

Can I decide to stop being part of the study once I've started?

Yes, you are free to withdraw from the study at any time without giving a reason, and your medical care will not be affected.